What is the main business of 7pharma?

The main business activity of 7pharma focuses on manufacture of other food products not elsewhere classified.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 27, 2017.

Where is the headquarters located?

The headquarters is located at: Aleja Komisji Edukacji Narodowej 93, 02-777 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

Yes, the company recorded a net profit of $11,604 in 2024, meaning the company decreased its profit by 17.8%.

7pharmasp. z o.o.

Manufacture of other food products not elsewhere classified

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2017-06-27

Share capital

5,000.00 PLN

Activity description

7pharma makes LiLY dietary supplements in the form of lollipops, tablets, gummies and fizzy drinks. Its products include tablets with vitamins C and D₃, a blend of 10 vitamins, and a throat formula; the company works with shops, pharmacies and wholesalers.

Registered address

Aleja Komisji Edukacji Narodowej 93, 02-777 Warszawa, Poland

Website

7pharma.pl

Electronic delivery address

AE:PL-10310-46459-RJTEB-27

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 73 days late).

202509/07/2026
202408/07/2025
202309/07/2024
202212/07/2023
202126/09/2022
202005/07/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Offer

Vitamin tablets
Vitamin lollipops
Vitamin gummies
Powdered soft drinks
Throat lozenges
Throat lollipops

Website technology

Website

WordPress

Authorized Representatives

Piotr Powałka – Management Board Member

Sławomir Wojewoda – President of the Management Board

Manner of representation

Two members of the management board acting jointly are authorized to make declarations of will on behalf of the company. In the case of a one-person management board, one member of the management board is authorized to make declarations of will on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Piotr Powałkaage 56	50	$675.31	50%
Sławomir Wojewodaage 54	50	$675.31	50%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2017-03-16.

mBank
28 1140 2004 0000 3402 7675 3758

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jul 24, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Stołecznego Warszawy

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Oleofarmsp. z o.o.	$68,110,367.86	oleofarm.pl
Laboratoria Naturysp. z o.o.	$13,931,403.39	laboratorianatury.pl
Best Labsp. z o.o.	$11,045,123.42	bestlab.com.pl
Supplelabsp. z o.o. + limited partnership	$5,146,355.45	supplelab.pl
Noble Healthsp. z o.o.	$4,558,481.50	noblehealth.com
Lab88sp. z o.o.	$1,707,981.35	lab88.pl
Pharmavenesp. z o.o.	$783,187.61	pharmavene.com
Nexon Pharmasp. z o.o.	$574,250.90	nexonpharma.pl
Eliavitsp. z o.o.	$209,400.77	eliavit.pl
Lycopharmsp. z o.o.	$203,130.49	lycopharm.com